DNTP Laboratory LLC

DNTP Laboratory LLC was paid $2.12M by Medicaid between Dec 2021 and Nov 2024, across 8 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 63% of everything it billed.

33Billing provider infoDNTP LABORATORY LLC
TEANECK, NJ 07666

33aNPI1629737200assigned 12/10/2021

33bProvider typePhysiological Laboratory

28Total paid$2.12M

24GClaims69,264

24DCodes billed8

24AFirst – last monthDec 2021 – Nov 2024

Compared with peers

Next to other Physiological Laboratory providers in New Jersey

Rank by total paid#1 of 6

Median peer was paid$405.93

This provider vs. median5,232×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	630	$13K
2022	57,621	$1.70M
2023	10,309	$386K
2024incomplete	704	$30K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	63%	22,602	16,243	$1.34M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	21%	21,842	15,606	$436K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	6.6%	17,863	12,178	$141K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	5.4%	3,510	3,137	$115K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	3.6%	1,330	1,205	$77K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	<1%	282	278	$9K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	229	212	$6K
99000		<1%	1,606	1,409	$8.02

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAHSAN, MD (PRESIDENT)

Same official

Other billing entities under AHSAN, MD

Full network →

Provider	Location	Paid
Bari Home Care LLC	Ronkonkoma, NY	$189.66M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.